Search Results - Jan Poolman

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Building teams to create innovative new vaccines by Jan Poolman

    Published in Human Vaccines & Immunotherapeutics (2018-12-01)
    Get full text
    Article


  2. 2

    Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines by Chakkumkal Anish, Michel Beurret, Jan Poolman

    Published in npj Vaccines (2021-12-01)
    Get full text
    Article


  3. 3

    Nueva generación de Vacunas Conjugadas Antimeningococica: Fundamentos y Posibilidades a escala Mundial by Jacqueline Miller, Jan Poolman, Dominique Boutriau

    Published in VacciMonitor (2009-08-01)
    Get full text
    Article


  4. 4

    Unbiased identification of risk factors for invasive Escherichia coli disease using machine learning by Erik Clarke, Christel Chehoud, Najat Khan, Bart Spiessens, Jan Poolman, Jeroen Geurtsen

    Published in BMC Infectious Diseases (2024-08-01)
    Get full text
    Article


  5. 5

    Nueva generación de vacunas antimeningococica basadas en vesículas de membrana externa by Jan Poolman, Philippe Denoël, Nathalie Devos, Christiane Feron, Karine Goraj, Patricia Momin, Christine Tans, Vincent Weynants

    Published in VacciMonitor (2009-08-01)
    Get full text
    Article


  6. 6

    Economic and Disease Burden Associated with Invasive Escherichia coli Disease in the United States by Mark A. Schmidt, Maxim Blum, Judy L. Donald, Richard T. Meenan, Elvira Carrió, Jan Poolman, Maureen P. Neary, Thomas Verstraeten, Jeroen Geurtsen

    Published in Infectious Diseases and Therapy (2025-02-01)
    Get full text
    Article


  7. 7

    Colonization with <i>Escherichia coli</i> ST131-<i>H</i>30R (<i>H</i>30R) Corresponds with Increased Serum Anti-O25 IgG Levels and Decreased TNFα and IL-10 Responsiveness to <i>H</... by Brian D. Johnston, Connie Clabots, Tricia Bender, Stephen B. Porter, Germie van den Dobbelsteen, Jan Poolman, Paul Thuras, James R. Johnson

    Published in Pathogens (2023-04-01)
    Get full text
    Article


  8. 8

    A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTI by Carlos A. Fierro, Michal Sarnecki, Bart Spiessens, Oscar Go, Tracey A. Day, Todd A. Davies, Germie van den Dobbelsteen, Jan Poolman, Darren Abbanat, Wouter Haazen

    Published in npj Vaccines (2024-06-01)
    Get full text
    Article


  9. 9

    Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized,... by Megumi Inoue, Tetsuro Ogawa, Hiroshi Tamura, Yosuke Hagiwara, Yuki Saito, Darren Abbanat, Germie van den Dobbelsteen, Peter Hermans, Stefan Thoelen, Jan Poolman, Patricia Ibarra de Palacios

    Published in Human Vaccines & Immunotherapeutics (2018-09-01)
    Get full text
    Article


Search Tools: